[1] Jabbar S, Drury J, Fordham JN, et al. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis[J]. J Clin Pathol, 2011, 64(4):354-357.[2] 陈秋生, 林春燕, 严文健, 等. 甘草酸促进雌二醇分泌拮抗去卵巢大鼠骨质疏松的影响研究[J]. 河北医学, 2016, 22(3):474-477.[3] Zhang L, Shen C, Chu J. Icariin Decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of alzheimer's disease[J]. Int J Biol Sci, 2014, 10(2):181-191.[4] Kapoor S. Icariin and its emerging role in the treatment of osteoporosis[J].Chin Med J,2013,126(2):400.[5] Yang L, Yu Z, Qu H, et al. Comparative effects of hispidulin, genistein, and icariin with estrogen on bone tissue in ovariectomized rats[J].Cell Biochem Biophys, 2014,70(1):485-490.[6] Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women:a 24-month randomized, double-blind and placebo-controlled trial[J]. J Bone Miner Res, 2007,22(7):1072-1079.[7] Zhang J,Song J,Shao J.Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice[J].Int J Clin Exp Med, 2015,8(5):7306-7314.[8] Hsieh TP, Sheu SY, Sun JS, et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis[J]. Phytomedicine,2011,18(2/3):176-185.[9] Ji X, Chen X, Yu X. Micro RNAs in osteoclasto genesis and function:potential therapeutic targets for osteoporosis[J]. Int J Mol Sci, 2016,17(3):349-365.[10] 刘波,张睿,徐彭,等.淫羊藿对去卵巢大鼠骨质疏松的影响[J].中国实验方剂学杂志,2013,19(7):178-181.[11] Li GW, Xu Z, Chang SX, et al. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis[J]. Menopause,2014,21(9):1007-1016.[12] Liu M, Zhong C, He RX, et al. Icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis[J].Chin Med J, 2012,125(10),1784-1789.[13] Wei QS, Huang L, Chen XH, et al. Effect of whole body vibration therapy on circulating serotonin levels in an ovariectomized rat model of osteoporosis[J]. Iran J Basic Med Sci,2014,17(1):62-68.[14] 何渝煦,魏庆中,熊启良,等. 骨质疏松性骨折与骨密度关系的研究进展[J]. 中国骨质疏松杂志,2014,20(2):219-224.[15] Grzegorzewska AE,Mlot-Michalska M.Bone mineral density,its predictors,and outcomes in peritoneal dialysis patients[J].Adv Perit Dial,2011,27:140-145.[16] Mlakar SJ, Prezeljb J, Marca J. Testing.GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women:novel involvement of glutathione Stransferases in bone remodeling process[J].Maturitas,2012,71(2):180-187.[17] Zhang MM, Zhang YH, Mao WX, et al. Correlation between BMD and TRACP,CTX-1,BALP,BGP,calcium and phosphorus metabolism indicator in 1084 female[J]. Chin J Osteoporos,2013,19(9):902-906.[18] Mancini,Moradi-Bidhendi N,Becherini L,et al. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent[J].Biochem Biophys Res Commun,2000, 274(2):477-481.[19] Leidi M, Dellera F, Mariotti M, et al. Nitric oxide mediates low magnesium inhibition of osteoblast-like cell proliferation[J]. J Nutr Biochem.,2012,23(10):1224-1229.[20] 陈基敏,陈咸川,谢吟灵.阿仑膦酸钠对绝经后女性骨质疏松患者动脉粥样硬化影响的研究[J].中国实验诊断学,2016,20(4):544-547.[21] 高雷,高华增,任艳.绝经后骨质疏松症相关骨代谢指标、细胞因子IFG-1的临床观察[J].中国实验诊断学,2014,18(6):919-921. |